The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.90BCNY
282.10M · vs all stocks (USD)
Updated Aug 21, 2026
Revenue (TTM)
193.03MCNY
28.71M · vs all stocks (USD)
Updated Aug 21, 2026
Profit Margin
-66.19%
Updated Aug 21, 2026
Beta
0.8150x
vs all stocks
Updated Aug 21, 2026
52-Week Change
-37.90%
vs all stocks
Updated Aug 21, 2026
Market Capitalization
1.90BCNY
282.10M · vs all stocks (USD)
Updated Aug 21, 2026
Enterprise Value
1.90BCNY
282.94M · vs all stocks (USD)
Updated Aug 21, 2026
Price to Sales (TTM)
9.68x
Updated Aug 21, 2026
Price to Book (MRQ)
3.23x
Updated Aug 21, 2026
Enterprise to Revenue
9.86x
Updated Aug 21, 2026
Enterprise to EBITDA
-16.60x
Updated Aug 21, 2026
Gross Margin
23.18%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 6.35%.Updated Aug 21, 2026
Profit Margin
-66.19%
Updated Aug 21, 2026
Operating Margin
-52.02%
Updated Aug 21, 2026
Return on Assets (TTM)
-9.34%
Updated Aug 21, 2026
Return on Equity (TTM)
-21.86%
Updated Aug 21, 2026
Revenue (TTM)
193.03MCNY
28.71M · vs all stocks (USD)
Updated Aug 21, 2026
Revenue per Share (TTM)
2.49CNYUpdated Aug 21, 2026
Quarterly Revenue Growth
-24.30%
Updated Aug 21, 2026
Gross Profit (TTM)
12.25MCNY
1.82M · vs all stocks (USD)
Updated Aug 21, 2026
EBITDA (TTM)
-114.61MCNY
-17.04M · vs all stocks (USD)
Updated Aug 21, 2026
Net Income (TTM)
-127.77MCNY
-19.00M · vs all stocks (USD)
Updated Aug 21, 2026
Quarterly Earnings Growth (YoY)
-31.47%
Updated Aug 21, 2026
Operating Cash Flow (TTM)
-14.92MCNY
-2.22M · vs all stocks (USD)
Updated Aug 21, 2026
Levered Free Cash Flow (TTM)
-18.39MCNY
-2.73M · vs all stocks (USD)
Updated Aug 21, 2026
Payout Ratio
0.00%
Updated Aug 21, 2026
Minority Interest (Equity)
-7.71MCNYFY2025 · Dec 31, 2025
Revenue
206.51MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
190.33MCNYFY2025 · Dec 31, 2025
Gross Profit
16.18MCNYFY2025 · Dec 31, 2025
Operating Income
-97.81MCNY
-14.55M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-125.47MCNYFY2025 · Dec 31, 2025
Income Tax Expense
4.73MCNYFY2025 · Dec 31, 2025
Net Income
-130.20MCNYFY2025 · Dec 31, 2025
EBIT
-122.18MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-58.11MCNYFY2025 · Dec 31, 2025
Research & Development
48.16MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
15.38MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
4.75MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
1.73MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
3.30MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-1.56CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-1.56CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
77.41MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
77.41MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-130.20MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
9.44MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-49.09MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-50.03MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
89.46MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-130.20MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
3.85MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
57.85MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
19.41MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-936.34KCNYFY2025 · Dec 31, 2025
Purchase of Investments
-227.00MCNYFY2025 · Dec 31, 2025
Sale of Investments
247.38MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
19.45MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
93.27MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-83.01MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-2.72MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-3.68MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
3.87MCNYFY2025 · Dec 31, 2025
Shares Outstanding
77.33MSharesUpdated Aug 21, 2026
Float Shares
27.27MSharesUpdated Aug 21, 2026
% Held by Insiders
65.66%
vs all stocks
Updated Aug 21, 2026
% Held by Institutions
0.24%
vs all stocks
Updated Aug 21, 2026
Total Cash (MRQ)
63.39MCNY
9.43M · vs all stocks (USD)
Updated Aug 21, 2026
Total Cash per Share (MRQ)
0.8200CNYUpdated Aug 21, 2026
Total Debt (MRQ)
107.13MCNY
15.93M · vs all stocks (USD)
Updated Aug 21, 2026
Total Debt to Equity (MRQ)
0.1882x
Updated Aug 21, 2026
Current Ratio (MRQ)
1.97x
Updated Aug 21, 2026
Book Value per Share (MRQ)
7.48CNYUpdated Aug 21, 2026
Total Assets
919.21MCNY
136.70M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
516.38MCNYFY2025 · Dec 31, 2025
Total Liabilities
327.82MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
402.83MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
62.10MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
265.72MCNYFY2025 · Dec 31, 2025
Cash
92.25MCNYFY2025 · Dec 31, 2025
Cash Equivalents
77.68KCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
92.32MCNYFY2025 · Dec 31, 2025
Accounts Receivable
334.26MCNYFY2025 · Dec 31, 2025
Inventory
19.72MCNYFY2025 · Dec 31, 2025
Accounts Payable
141.97MCNYFY2025 · Dec 31, 2025
Short-term Debt
74.82MCNYFY2025 · Dec 31, 2025
Long-term Debt
24.00MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
1.17MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
77.33MCNYFY2025 · Dec 31, 2025
Retained Earnings
-508.96MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
591.39MCNY
87.95M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
18.51CNYUpdated Aug 21, 2026
52-Week High
57.76CNYUpdated Aug 21, 2026
52-Week Change
-37.90%
vs all stocks
Updated Aug 21, 2026
Beta
0.8150x
vs all stocks
Updated Aug 21, 2026
50-Day MA
23.75CNYUpdated Aug 21, 2026
200-Day MA
34.90CNYUpdated Aug 21, 2026
Avg 10-Day Volume
1.24MSharesUpdated Aug 21, 2026
Avg 30-Day Volume
1.46MSharesUpdated Aug 21, 2026
Diluted EPS (TTM)
-1.65CNYUpdated Aug 21, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.81: safe zoneNotable
Altman Z-Score: 2.81
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Scale
Revenue is $28.71M, lower than 95% of all stocks globallySignificant